Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jakob Steen Andersen

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Ugeskrift for Laeger|February 23, 2007
[Methods for cost-effectiveness evaluation of intensive care]Lars Heslet, Jakob Steen Andersen, Hans Keiding
Studies in Health Technology and Informatics|June 15, 2010
Quality improvements based on detailed and precise terminologyIda Tvede, Kirsten Bredegaard, Jakob Steen Andersen
Ugeskrift for Laeger|February 23, 2007
[Diagnosis Related Groups in intensive care units--cost model for critically ill patients]Jakob Steen Andersen, Niels-Erik Drenck, Hans Keiding
Ugeskrift for Laeger|March 31, 2004
[Recombinant activated protein C: from evidence to clinical practice. Clinical practice guidelines for the use of activated proteins C in the treatment of severe sepsis]Lars Heslet, Jørn Dalsgaard Nielsen, Jens Schierbeck, et al.
Danish Medical Journal|March 3, 2012
Intensive care of haematological patientsTobias Magid, Nicolai Haase, Jakob Steen Andersen, et al.
Biologics : Targets & Therapy|August 27, 2009
Inhalation of activated protein C: A possible new adjunctive intervention in acute respiratory distress syndromeLars Heslet, Jakob Steen Andersen, Henrik Sengeløv, et al.
Ugeskrift for Laeger|February 12, 2010
[Necrotizing fasciitis]Anders Peter Skovsen, Jan Bonde, Jakob Steen Andersen, et al.
Ugeskrift for Laeger|February 23, 2007
[Clinical database for intensive care patients]Ebbe Rønholm, Steffen Christensen, Jakob Steen Andersen, et al.
Ugeskrift for Laeger|November 4, 2008
[Mortality and morbidity in surgery for abdominal aortic aneurysm]Ann Boecher Secher Banke, Jakob Steen Andersen, Lars Heslet, et al.
Acta Anaesthesiologica Scandinavica|April 26, 2019
Piperacillin/tazobactam vs carbapenems for patients with bacterial infection: Protocol for a systematic reviewMarie Warrer Petersen, Anders Perner, Fredrik Sjövall, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Ugeskrift for Laeger|February 23, 2007
[Methods for cost-effectiveness evaluation of intensive care]Lars Heslet, Jakob Steen Andersen, Hans Keiding
Studies in Health Technology and Informatics|June 15, 2010
Quality improvements based on detailed and precise terminologyIda Tvede, Kirsten Bredegaard, Jakob Steen Andersen
Ugeskrift for Laeger|February 23, 2007
[Diagnosis Related Groups in intensive care units--cost model for critically ill patients]Jakob Steen Andersen, Niels-Erik Drenck, Hans Keiding
Ugeskrift for Laeger|March 31, 2004
[Recombinant activated protein C: from evidence to clinical practice. Clinical practice guidelines for the use of activated proteins C in the treatment of severe sepsis]Lars Heslet, Jørn Dalsgaard Nielsen, Jens Schierbeck, et al.
Danish Medical Journal|March 3, 2012
Intensive care of haematological patientsTobias Magid, Nicolai Haase, Jakob Steen Andersen, et al.
Biologics : Targets & Therapy|August 27, 2009
Inhalation of activated protein C: A possible new adjunctive intervention in acute respiratory distress syndromeLars Heslet, Jakob Steen Andersen, Henrik Sengeløv, et al.
Ugeskrift for Laeger|February 12, 2010
[Necrotizing fasciitis]Anders Peter Skovsen, Jan Bonde, Jakob Steen Andersen, et al.
Ugeskrift for Laeger|February 23, 2007
[Clinical database for intensive care patients]Ebbe Rønholm, Steffen Christensen, Jakob Steen Andersen, et al.
Ugeskrift for Laeger|November 4, 2008
[Mortality and morbidity in surgery for abdominal aortic aneurysm]Ann Boecher Secher Banke, Jakob Steen Andersen, Lars Heslet, et al.
Acta Anaesthesiologica Scandinavica|April 26, 2019
Piperacillin/tazobactam vs carbapenems for patients with bacterial infection: Protocol for a systematic reviewMarie Warrer Petersen, Anders Perner, Fredrik Sjövall, et al.
Pageof 2